Trinity revenues up a fifth in Q2

Dublin-based Trinity Biotech, which trades on the ISEQ and on New York’s NASDAQ, has announced results for the quarter ended June 30, 2004.

Trinity revenues up a fifth in Q2

Dublin-based Trinity Biotech, which trades on the ISEQ and on New York’s NASDAQ, has announced results for the quarter ended June 30, 2004.

Revenues in the quarter increased 22.6% to $20.1m (€16.7m) compared to $16.4m (€13.6m) in quarter one.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited